Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TherapeuticsMD, Inc. - Common Stock (NQ:TXMD)

1.120 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,415
Open 1.130
Bid (Size) 1.110 (3)
Ask (Size) 1.140 (104)
Prev. Close 1.120
Today's Range 1.116 - 1.130
52wk Range 0.7200 - 2.440
Shares Outstanding 9,953,290
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TherapeuticsMD Swings to Profit in Q2
Via The Motley Fool
TherapeuticsMD Announces Second Quarter 2025 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire

Performance

YTD
-28.7%
-28.7%
1 Month
-4.3%
-4.3%
3 Month
-22.8%
-22.8%
6 Month
+31.0%
+31.0%
1 Year
-41.7%
-41.7%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
Via InvestorPlace
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023
Via InvestorPlace
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
TherapeuticsMD Announces First Quarter 2025 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
TherapeuticsMD Announces Full Year 2024 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session.
Via Chartmill
Top movers in Friday's session
Via Chartmill
TherapeuticsMD Announces Third Quarter 2024 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Via Benzinga
TherapeuticsMD Announces Second Quarter 2024 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
TherapeuticsMD Announces First Quarter 2024 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
TherapeuticsMD Announces Full Year 2023 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
5 Value Stocks In The Healthcare Sector
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
TherapeuticsMD Announces Third Quarter 2023 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
Nasdaq Jumps 100 Points; US Trade Deficit Widens In September
Via Benzinga
Topics Stocks
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga

Frequently Asked Questions

Is TherapeuticsMD, Inc. - Common Stock publicly traded?
Yes, TherapeuticsMD, Inc. - Common Stock is publicly traded.
What exchange does TherapeuticsMD, Inc. - Common Stock trade on?
TherapeuticsMD, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TherapeuticsMD, Inc. - Common Stock?
The ticker symbol for TherapeuticsMD, Inc. - Common Stock is TXMD on the Nasdaq Stock Market
What is the current price of TherapeuticsMD, Inc. - Common Stock?
The current price of TherapeuticsMD, Inc. - Common Stock is 1.120
When was TherapeuticsMD, Inc. - Common Stock last traded?
The last trade of TherapeuticsMD, Inc. - Common Stock was at 08/28/25 04:00 PM ET
What is the market capitalization of TherapeuticsMD, Inc. - Common Stock?
The market capitalization of TherapeuticsMD, Inc. - Common Stock is 11.15M
How many shares of TherapeuticsMD, Inc. - Common Stock are outstanding?
TherapeuticsMD, Inc. - Common Stock has 11M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.